You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

188 Results
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Intent: Curative, Palliative
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Drug
Other Name(s): Camptosar®
Dec 1969
Drug
Other Name(s): Sarclisa®
Dec 1969
This page is for people who have a type of human papillomavirus (HPV) that can sometimes cause cervical cancer. If you have questions about your...
The resources in this toolkit will help radiologists and other imaging professionals provide consistent and high-quality imaging according to best...

Pages